PDCD1 and neoplasm: They observed that efficient silencing of PD-1 significantly inhibited the immunosuppressive effects of the TME in subcutaneous prostate and leukemia xenograft mouse models, enhancing tumor-killing effects and extending the activation duration of CAR-T cells [75].